Contents
What You Need to Know About Dexamethasone Suppression Tests
Published: May 26, 2024
Dexamethasone suppression tests (DSTs) are crucial for identifying excessive cortisol production, often linked to Cushing syndrome. This article breaks down how DSTs work and their role in medical diagnostics.
Understanding Dexamethasone Suppression Tests
Dexamethasone suppression tests are used to check how your body responds to a steroid called dexamethasone, which is much stronger than the body's natural cortisol. If your body produces too much cortisol, it could signal a condition like Cushing syndrome. During the test, dexamethasone is given to see if it suppresses cortisol production, helping doctors diagnose issues with cortisol regulation.
The Lowdown on Low-Dose Tests
The low-dose DST is a common method to detect abnormal cortisol levels. It's a simple test where a small dose of dexamethasone is taken, usually overnight, followed by a blood test in the morning. If cortisol levels drop, it typically means your body is responding normally. However, if cortisol levels remain high, it might indicate an underlying issue like Cushing syndrome.
High-Dose Tests: When Are They Used?
High-dose DSTs are less commonly used and involve taking a much larger dose of dexamethasone. These tests help differentiate between different causes of high cortisol levels. For example, they can determine if a problem originates in the pituitary gland or elsewhere. Although not routine, these tests provide important clues about the source of cortisol overproduction.
Frequently Asked Questions
Dexamethasone is a potent steroid used to assess cortisol suppression in the body.
It's a standard test to check for excess cortisol production linked to Cushing syndrome.
Yes, obesity can influence results, sometimes requiring adjustments in dexamethasone dosage.
A normal result shows cortisol levels under 2 mcg/dL after dexamethasone intake.
Wrapping Up
DSTs are essential tools in diagnosing cortisol-related disorders, providing insights into hormonal imbalances.
References
- Nieman LK, Biller BM, Findling JW, et al. The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2008; 93:1526.
- Findling JW, Raff H. DIAGNOSIS OF ENDOCRINE DISEASE: Differentiation of pathologic/neoplastic hypercortisolism. Eur J Endocrinol 2017; 176:R205.
This article has been reviewed for accuracy by one of the licensed medical doctors working for Doctronic. Always discuss health information with your healthcare provider.
AI Doctor Visit Required
Appointments available 24/7
Top licensed doctors
Available in all 50 states
Full service care
Prescriptions, referrals & treatment
No insurance needed
All notes available in Doctronic
15-min consultation. No hidden costs.
AI Doctor Visit Required
Please Chat With Our AI Doctor First
Our AI doctor assessment helps our human doctors prepare for your video visit and provide better care
For safety reasons we have been forced to end this consultation.
If you believe this is a medical emergency please call 911 or your local emergency services immediately.
If you are experiencing emotional distress, please call the the Suicide & Crisis Lifeline at 988 or your local crisis services immediately.
Contact us
You can also email us at help@doctronic.ai
We aim to reply within 5-7 days
How likely are you to recommend Doctronic to friends or family?